Contract Awarded For Delivery Of Medicinal Products Containing Active Substances Trastuzumab Deruxtecan, Acalbrutinib, Palivizumab, Durvalumab, Olaparib, Ravulizumab
delivery Of Medicinal Products Containing Active Substances Trastuzumab Deruxtecan, Acalb
TK ID 529822069
Document Type
Contract Awards
Tender Summary
Contract Awarded For Delivery Of Medicinal Products Containing Active Substances Trastuzumab Deruxtecan, Acalbrutinib, Palivizumab, Durvalumab, Olaparib, Ravulizumab
delivery Of Medicinal Products Containing Active Substances Trastuzumab Deruxtecan, Acalb
Action Deadline
30 Jun 2026